000 01540 a2200481 4500
005 20250512083535.0
264 0 _c19850801
008 198508s 0 0 eng d
022 _a0036-8075
024 7 _a10.1126/science.4012308
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSikic, B I
245 0 0 _aDissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.
_h[electronic resource]
260 _bScience (New York, N.Y.)
_cJun 1985
300 _a1544-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCell Line
650 0 4 _aChemical Phenomena
650 0 4 _aChemistry
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHeart
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIsoenzymes
650 0 4 _aL-Lactate Dehydrogenase
_xanalysis
650 0 4 _aMice
650 0 4 _aMyocardium
_xenzymology
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPregnancy
700 1 _aEhsan, M N
700 1 _aHarker, W G
700 1 _aFriend, N F
700 1 _aBrown, B W
700 1 _aNewman, R A
700 1 _aHacker, M P
700 1 _aActon, E M
773 0 _tScience (New York, N.Y.)
_gvol. 228
_gno. 4707
_gp. 1544-6
856 4 0 _uhttps://doi.org/10.1126/science.4012308
_zAvailable from publisher's website
999 _c4017992
_d4017992